Current Molecular Pharmacology


Michael Kahn
(16435 citations)
Beckman Research Institute
City of Hope
Duarte, CA 91010-3000

Personal Subscription
Become EABM
Become Reviewer

Meet Our Editorial Board Member: free to download

Volume:9   Issue: 3
Pp: 181-181
Derek S. Tan
DOI: 10.2174/187446720903160906121052

Editorial (Thematic Issue: Clinical Advances in Immuno-oncology – Progress Towards Selective Cure) free to download

Volume:9   Issue: 3
Pp: 182-182
Xin Liu and Chandra P. Belani
DOI: 10.2174/1874467208999150716103938

Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives

Volume:9   Issue: 3
Pp: 183-195
Shawn J. Rice, Bruce Miller, Matthias Wagman, Daniel S. Jamorabo, Xin Liu and Chandra P. Belani
DOI: 10.2174/1874467208666150716120108

Immunotherapy of Melanoma

Volume:9   Issue: 3
Pp: 196-207
Ahmad A. Tarhini
DOI: 10.2174/1874467208666150716120238

Immunotherapy in Breast Cancer- Paving New Roads?

Volume:9   Issue: 3
Pp: 208-216
Cristina I. Truica and Allison S. Cleary
DOI: 10.2174/1874467208666150716120427

A New Era of Immunotherapy in Prostate Cancer

Volume:9   Issue: 3
Pp: 217-225
Christopher Pizzola, Syed M. Rizvi and Monika Joshi
DOI: 10.2174/1874467208666150716120551

Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma

Volume:9   Issue: 3
Pp: 226-230
Salah Almokadem
DOI: 10.2174/1874467208666150716120658

Immunotherapy in Bladder Cancer

Volume:9   Issue: 3
Pp: 242-251
Monali Vasekar, David Degraff and Monika Joshi
DOI: 10.2174/1874467208666150716120945

Current Immunotherapies for Renal Cell Carcinoma

Volume:9   Issue: 3
Pp: 252-263
Mhd. Yaser Al-Marrawi and Sheldon L. Holder
DOI: 10.2174/1874467208666150716121116

Novel Immunotherapies for Hematological Malignancies

Volume:9   Issue: 3
Pp: 264-271
Monali Vasekar, Syed Rizvi, Xin Liu, Kent E. Vrana and Hong Zheng
DOI: 10.2174/1874467208666150716121253

Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell Potency

Volume:9   Issue: 3
Pp: 272-279
Yusuke Higuchi, Cu Nguyen, Shin-Ya Yasuda, Michael McMillan, Kouichi Hasegawa and Michael Kahn
DOI: 10.2174/1874467208666150526155146